510(k) device
ADVIA Chemistry Enzymatic Hemoglobin Ale (Alc_E) Assay
Siemens Healthcare Diagnostics, Inc. · Hemoglobin A1c Test System (PDJ, Class II) · First FDA decision Dec 4, 2017, newest Jul 2, 2021Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "ADVIA Chemistry Enzymatic"
MAUDE reports
4
Brand "ADVIA Chemistry Enzymatic", since 2015
PubMed studies
0
Mentioning "ADVIA Chemistry Enzymatic"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ADVIA Chemistry Enzymatic Hemoglobin Ale (Alc_E) Assay
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K200256 · Decided Jul 2, 2021 · 515 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
K171771 · Decided Dec 4, 2017 · 173 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Glycated Hemoglobin/Glycated ProteinNational determinationOn the books190.21Updated Oct 1, 2026
- Glycated Hemoglobin/Glycated Protein (Addition of ICD-9-CM 271.3, Intestinal disaccharidase deficiencies and disaccharide malabsorption)Coding analysisReview closedCAG-00336NUpdated Sep 14, 2026
- Glycated Hemoglobin/Glycated Protein (Addition of CPT Code 83037, Hemoglobin; glycosylated [A1c] by device cleared by FDA for home use)Coding analysisReview closedCAG-00373NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "ADVIA Chemistry Enzymatic", any status and sponsor, newest update first.
No registered device study names "ADVIA Chemistry Enzymatic".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ADVIA Chemistry Enzymatic", and for the whole product code for context.
This brand
4 reports: 4 malfunction, 0 injury, 0 death
Whole product code PDJ
218 reports: 216 malfunction, 2 injury, 0 death
Newest reports for this brand
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
1219913-2023-00278 · Received Nov 3, 2023 · Event dated Sep 28, 2023
Device type: Enzymatic Method, Creatinine (JFY)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
1219913-2023-00279 · Received Nov 3, 2023 · Event dated Sep 29, 2023
Device type: Enzymatic Method, Creatinine (JFY)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
SIEMENS HEALTHCARE DIAGNOSTICS INC.
2432235-2020-00391 · Received Sep 30, 2020 · Event dated Sep 3, 2020
Device type: Enzymatic Method, Creatinine (JFY)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
1 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Siemens Healthcare Diagnostics, Inc.
Z-2703-2026 · Started Jun 8, 2026 · Posted by FDA Jul 8, 2026
Reason given: The potential for intermittent well-to-well bias on the A1c_E assay on the Atellica CH and Atellica CI analyzer which could cause falsely depressed or falsely elevated HbA1c patient results.
Cause as FDA categorized it: Under Investigation by firm · Device type: Hemoglobin A1c Test System (PDJ)
- Atellica CH Enzymatic Hemoglobin A1c (A1c_E); Siemens Material Number (SMN): 11097536;Open, Classified
Siemens Healthcare Diagnostics, Inc.
Z-1657-2026 · Started Feb 23, 2026 · Posted by FDA Mar 27, 2026
Reason given: A potential for depressed results for Atellica CH A1c_E when processing Atellica CH RCRP on the same analyzer. Customers processing A1c_E and RCRP on separate analyzers are not impacted by the recall. The frequency and magnitude of the negative bias and imprecision increase over time and are not consistent with the...
Cause as FDA categorized it: Process control · Device type: Hemoglobin A1c Test System (PDJ)
- Atellica CH Enzymatic Hemoglobin A1c (A1c_E/A1c_H), Siemens Material Number 11097536Open, Classified
Siemens Healthcare Diagnostics, Inc.
Z-0929-2022 · Started Feb 9, 2022
Reason given: Siemens Healthcare Diagnostics Inc. has confirmed the potential for reagent carryover impacting quality control (QC), patient samples, and calibrator results.
Cause as FDA categorized it: Device Design · Device type: Hemoglobin A1c Test System (PDJ)
Published research
The most relevant PubMed records for "ADVIA Chemistry Enzymatic"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PDJ.
- Tosoh Automated Glycohemoglobin Analyzer HLC-723GR01Tosoh Bioscience, Inc. · 510(k) 2025
- Afinion HbA1c Dx on Afinion 2Alere Technologies AS · 510(k) 2018
- Hemoglobin A1c Assay, Hemoglobin A1c Calibrators, Hemoglobin A1c ControlsAbbott Laboratories · 510(k) 2015
- H100Plus Hemoglobin Testing SystemShenzhen Lifotronic Technology Co., Ltd. · 510(k) 2026
- Medconn 8K Glycated Hemoglobin Test SystemShanghai Medconn Medical Technology Co., Ltd. · 510(k) 2026
- Medconn Glycated Hemoglobin Test systemShanghai Medconn Medical Technology Co., Ltd. · 510(k) 2025
- Hipro Glycosylated Hemoglobin (HbA1c) Test SystemShijiazhuang Hipro Biotechnology Co., Ltd. · 510(k) 2024
- Tina-quant Hemoglobin A1cDx Gen.3Roche Diagnostics Operations (Rdo) · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.